Metformin has been a cornerstone in managing type 2 diabetes primarily known for its effects on the liver and gut. For over 60 years, it has been prescribed to help control blood sugar levels. However, new research has revealed that metformin also plays a crucial role in brain health, potentially altering how we understand its therapeutic effects.
Recent findings indicate that metformin works in the brain by shutting down a protein called Rap1 in the ventromedial hypothalamus. This action activates SF1 neurons, which are essential for regulating energy balance and metabolism. According to researcher Makoto Fukuda, “This discovery changes how we think about metformin. It’s not just working in the liver or the gut, it’s also acting in the brain.”
Moreover, metformin is recognized for its broader health benefits, including its ability to slow brain aging. A 2025 study highlighted that users of metformin had a 30% lower risk of dying before age 90 compared to those using sulfonylurea, further emphasizing its potential as a gerotherapeutic.
Fukuda elaborated on the drug’s unique interaction with the brain, stating, “We found that while the liver and intestines need high concentrations of the drug to respond, the brain reacts to much lower levels.” This suggests that metformin could be effective in lower doses for neurological benefits.
In addition to its diabetes management capabilities, metformin has been shown to reduce wear and tear in the brain and may lower the risk of long COVID. These findings could lead to new treatment strategies that incorporate metformin for conditions beyond diabetes.
Despite these promising developments, it is essential to approach the findings with caution. As research continues, health professionals are urged to consider the implications of metformin’s effects on brain health in their treatment plans.
Details remain unconfirmed regarding the full extent of metformin’s impact on neurological health, but the initial evidence is compelling enough to warrant further investigation. Observers are keenly watching how these findings will influence future research and clinical practices.
